Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area

키워드

참고문헌 (30)

1. Mao YP, "Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging", Int J Radiat Oncol Biol Phys, 73, pp.1326~1334 (2009)[DOI]
2. Sun Y, "Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial", Lancet Oncol, 17, pp.1509~1520 (2016)[DOI]
3. Kuderer NM, "Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients", Cancer, 106, pp.2258~2266 (2006)[DOI]
4. Lyman GH, "Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy", Cancer, 117, pp.1917~1927 (2011)[DOI]
5. Chen Y, "Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients", BMC Cancer, 17, pp.242~ (2017)[DOI]
6. Lee CY, "Early-onset neutropenia during perioperative chemotherapy is predictive of increased survival in patients with completely resected non-small cell lung cancer: a retrospective analysis", Anticancer Res, 33, pp.2755~2761 (2013)
7. Kishida Y, "Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03", Br J Cancer, 101, pp.1537~1542 (2009)[DOI]
8. Di Maio M, "Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials", Lancet Oncol, 6, pp.669~677 (2005)[DOI]
9. Tewari KS, "Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the Gynecologic Oncology Group", Gynecol Oncol, 133, pp.439~445 (2014)[DOI]
10. Kim JJ, "Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?", Acta Obstet Gynecol Scand, 89, pp.623~628 (2010)[DOI]
11. Kumpulainen EJ, "Neutropenia during adjuvant chemotherapy of breast cancer is not a predictor of outcome", Acta Oncol, 48, pp.1204~1206 (2009)[DOI]
12. Bogani G, "Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer", Eur J Obstet Gynecol Reprod Biol, 208, pp.41~45 (2017)[DOI]
13. Miyoshi N, "Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer", J Surg Oncol, 99, pp.302~306 (2009)[DOI]
14. Blay JY, "Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia", J Clin Oncol, 14, pp.636~643 (1996)[DOI]
15. Crawford J, "Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management", Cancer, 100, pp.228~237 (2004)[DOI]
16. Wong G, "Cancers after renal transplantation", Transplant Rev (Orlando), 22, pp.141~149 (2008)[DOI]
17. Xu C, "Establishing and applying nomograms based on the 8th edition of the UICC", AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy, 2017, pp.69, 99~107
18. Diakos CI, "Cancerrelated inflammation and treatment effectiveness", Lancet Oncol, 15, pp.e493~e503 (2014)[DOI]
19. Sherman RE, "Real-world evidence: what is it and what can it tell us?", N Engl J Med, 375, pp.2293~2297 (2016)[DOI]
20. Kaplan EL, "Nonparametric estimation from incomplete observations", J Am Stat Assoc, 53, pp.457~481 (1958)[DOI]
21. Neyeloff JL, "Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis", BMC Res Notes, 5, pp.52~ (2012)[DOI]
22. Li XH, "An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study", Cancer Med, 6, pp.310~319 (2017)[DOI]
23. Azab B, "The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer", Cancer Biomark, 14, pp.303~312 (2014)[DOI]
24. Ferrucci PF, "Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab", Ann Oncol, 27, pp.732~738 (2016)[DOI]
25. Liang W, "Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment", Chin J Cancer, 35, pp.98~ (2016)[DOI]
26. Peng H, "Prognostic value of the cumulative cisplatin dose during concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a secondary analysis of a prospective phase III clinical trial", Oncologist, 21, pp.1369~1376 (2016)[DOI]
27. Burdach S, "Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors: an update after long-term followup from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria", Ann Oncol, 11, pp.1451~1462 (2000)[DOI]
28. Li-Ting Liu, "The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients", Cancer Research and Treatment, 50(1), pp.19~29 (2018), 대한암학회
29. Sun W, "Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio", Head Neck, 38(Suppl 1), pp.E1332~E1340 (2016)[DOI]
30. An X, "Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma", Tumour Biol, 32, pp.317~324 (2011)[DOI]

관련 논문AI추천